Activities

Activities

ShigOraVax logo_Final_191209.jpg

  • About us

  • Our Approach

  • Governance

  • Partners

  • News

  • Contact

  • More

    Use tab to navigate through the menu items.

    Our approach

    Aim & Work packages 

    ShigOraVax is dedicated to the early clinical development of an oral Shigella vaccine through phase II study in Africa

    ​

    ShigOraVax_Activities.png

    Strategy of ShigOraVax project

    ShigOraVax project is organised in seven complementary Work Packages, each led by a Work Package Leader.

    The following work packages are planned:

    Work package 1: Coordination
    Work package 2: Development and validation of immunological assays to assess immune response following vaccination with ShigOraVax
    Work package 3: Epidemiological baseline studies in Burkina Faso and Zambia
    Work package 4: Phase Ia/b clinical trial in The Netherlands and Burkina Faso
    Work package 5: Phase II/IIb clinical trial in Burkina Faso and Zambia
    Work package 6: Capacity strengthening and networking
    Work package 7: Dissemination, exploitation and communication
    Background
    Organisational Structure
    EDCTP Logo_03-Red_EDCTP.jpg

    This project is part of the EDCTP2 Programme supported by the European Union

    (RIA2018V-2308)

    EU emblem_flag_yellow_high (1).jpg
    ShigOraVax logo_Final_191209.jpg

    Connect

    Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

    • LinkedIn - White Circle
    • Twitter - White Circle

    Thanks for subscribing! If you have any questions or would like to unsubscribe contact us at communication@euvaccine.eu

    Privacy Policy  |  Imprint  |  Contact us  |  Back to top

    © 2022 European Vaccine Initiative. Designed by European Vaccine Initiative